Larsen, J. T., Shanafelt, T. D., Leis, J. F., LaPlant, B., Call, T., Pettinger, A., Hanson, C., Erlichman, C., Habermann, T. M., Reeder, C., Nikcevich, D., Bowen, D., Conte, M., Boysen, J., Secreto, C., Lesnick, C., Tschumper, R., Jelinek, D., Kay, N. E., & Ding, W. (n.d.). akt inhibitor MK‐2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study. American journal of hematology, 92(8), 759–763. http://access.bl.uk/ark:/81055/vdc_100047737984.0x00004f